Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,780 | 8,535 | 7,289 | 4,491 | 4,751 |
| Receivables | 3,965 | 3,058 | 2,661 | 4,672 | 3,378 |
| Inventories | 7,617 | 6,741 | 6,694 | 6,546 | 6,704 |
| TOTAL | $31,870 | $18,861 | $17,475 | $15,882 | $15,317 |
| Non-Current Assets | |||||
| PPE Net | 5,755 | 5,953 | 5,986 | 6,197 | 6,345 |
| Intangibles | 6,634 | 6,634 | 6,634 | 6,634 | 6,634 |
| Other Non-Current Assets | 3,850 | 3,701 | 1,852 | 1,911 | 1,697 |
| TOTAL | $16,239 | $16,288 | $14,472 | $14,742 | $14,676 |
| Total Assets | $48,108 | $35,149 | $31,947 | $30,624 | $29,993 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 435 | 354 | 400 | 511 | 583 |
| Accounts payable and accrued liabilities | 1,614 | 1,431 | 1,284 | 1,790 | 2,052 |
| Accrued Expenses | 4,810 | 4,693 | 4,026 | 3,779 | 3,941 |
| TOTAL | $7,080 | $6,694 | $5,878 | $6,304 | $6,795 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,207 | 1,389 | 1,433 | 1,473 | 1,664 |
| Deferred Revenues | 13 | 13 | 13 | 13 | 13 |
| Other Non-Current Liabilities | 2,260 | 1,812 | 1,811 | 2,307 | 2,790 |
| TOTAL | $15,495 | $3,233 | $3,279 | $3,818 | $4,496 |
| Total Liabilities | $22,575 | $9,927 | $9,157 | $10,122 | $11,291 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,011,282 | 1,011,282 | 1,011,282 | 1,011,282 | 1,011,282 |
| Common Shares | 1,011 | 1,011 | 1,011 | 1,011 | 1,011 |
| Retained earnings | -139,754 | -140,060 | -142,489 | -144,772 | -146,569 |
| Other shareholders' equity | -307 | -307 | -307 | -307 | -307 |
| TOTAL | $25,533 | $25,222 | $22,790 | $20,503 | $18,701 |
| Total Liabilities And Equity | $48,108 | $35,149 | $31,947 | $30,624 | $29,993 |